Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.

Drug testing is a harm reduction strategy that has been adopted by certain countries in Europe. Drug users are able to hand in their drugs voluntarily for chemical analysis of composition and dose. Drug users will be alerted about dangerous test results by the drug testing systems directly and through warning campaigns. An international collaborative effort was launched to combine data of drug testing systems, called the Trans European Drug Information (TEDI) project. Drug testing systems of Spain, Switzerland, Belgium, Austria, Portugal, and the Netherlands participated in this project. This study presents results of some of the main illicit drugs encountered: cocaine, ecstasy and amphetamine and also comments on new psychoactive substances (NPS) detected between 2008 and 2013. A total of 45 859 different drug samples were analyzed by TEDI. The drug markets of the distinct European areas showed similarities, but also some interesting differences. For instance, purity of cocaine and amphetamine powders was generally low in Austria, whilst high in Spain and the Netherlands. And the market for ecstasy showed a contrast: whereas in the Netherlands and Switzerland there was predominantly a market for ecstasy tablets, in Portugal and Spain MDMA (3,4-methylenedioxymethamphetamine) crystals were much more prevalent. Also, some NPS appearing in ecstasy seemed more specific for one country than another. In general, prevalence of NPS clearly increased between 2008 and 2013. Drug testing can be used to generate a global picture of drug markets and provides information about the pharmacological contents of drugs for the population at risk. Copyright © 2016 John Wiley & Sons, Ltd.

[1]  A. J. Waarlo,et al.  Participatory evaluation of a Dutch warning campaign for substance-users , 2008 .

[2]  A S Christophersen,et al.  Amphetamine designer drugs - an overview and epidemiology. , 2000, Toxicology letters.

[3]  S. Legleye,et al.  Composition, purity and perceived quality of street cocaine in France. , 2010, The International journal on drug policy.

[4]  J. Rovira.  Testeo y análisis de sustancias como práctica para una reducción de riesgos , 2002 .

[5]  M. Bossong,et al.  mCPP: an undesired addition to the ecstasy market , 2010, Journal of psychopharmacology.

[6]  T. Brunt,et al.  Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre. , 2015, Drug and alcohol dependence.

[7]  P. V. van Dijk,et al.  Content of ecstasy in the Netherlands: 1993-2008. , 2009, Addiction.

[8]  L. Orsolini,et al.  Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces , 2015, Human psychopharmacology.

[9]  M. Schaub,et al.  Drug Checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use - evaluation of zurich's drug checking services , 2011, Harm reduction journal.

[10]  C. Donovan.  Illegal leisure: the normalization of adolescent recreational drug use , 2000 .

[11]  E. Kaa,et al.  Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000. , 2003, Forensic science international.

[12]  D. Caldicott,et al.  Underground pill testing, down under. , 2005, Forensic science international.

[13]  J. Strang,et al.  Understanding reasons for drug use amongst young people: a functional perspective. , 2001, Health education research.

[14]  E. Tanner‐Smith,et al.  Pharmacological content of tablets sold as "ecstasy": results from an online testing service. , 2006, Drug and alcohol dependence.

[15]  R. Niesink,et al.  4-Fluoroamphetamine in the Netherlands: more than a one-night stand. , 2015, Addiction.

[16]  M. Farré,et al.  4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects , 2012, Journal of psychopharmacology.

[17]  M. Eide,et al.  Images in clinical medicine. Toxic effects of levamisole in a cocaine user. , 2011, New England Journal of Medicine.

[18]  M. Bossong,et al.  Methylone and mCPP, two new drugs of abuse? , 2005, Addiction biology.

[19]  O. Corazza,et al.  Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages. , 2014, The International journal on drug policy.

[20]  J. Ramsey,et al.  Analysis for Identification in Amnesty Bin Samples from Dance Venues , 2005, Therapeutic drug monitoring.

[21]  N. Fucci,et al.  Adulterants encountered in the illicit cocaine market. , 1998, Forensic Science International.

[22]  K. Maudens,et al.  4-Methyl-amphetamine: a health threat for recreational amphetamine users , 2013, Journal of psychopharmacology.

[23]  P. V. van Dijk,et al.  An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. , 2009, Addiction.

[24]  Gerra Gilberto,et al.  Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime (UNODC), Vienna. , 2013 .

[25]  J. V. van Amsterdam,et al.  Generic legislation of new psychoactive drugs , 2013, Journal of psychopharmacology.

[26]  M. Bellis,et al.  Healthy nightclubs and recreational substance use. From a harm minimisation to a healthy settings approach. , 2002, Addictive behaviors.

[27]  L. King,et al.  The new drug phenomenon. , 2014, Drug testing and analysis.

[28]  Anneke Poortman,et al.  Instability of the ecstasy market and a new kid on the block: mephedrone , 2011, Journal of psychopharmacology.

[29]  F. Schifano,et al.  Personality dimensions and psychopathological profiles of Ecstasy users , 2001, Human psychopharmacology.

[30]  I. Spruit.  Ecstasy Use and Policy Responses in the Netherlands , 1999 .

[31]  Pierre Margot,et al.  Optimization of HS-SPME/GC-MS analysis and its use in the profiling of illicit ecstasy tablets (Part 1). , 2009, Forensic science international.

[32]  G K L Butler,et al.  Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. , 2004, Drug and alcohol dependence.

[33]  J. Graf,et al.  Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. , 2011, Arthritis and rheumatism.

[34]  Claudio Vidal Giné,et al.  New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? , 2014, Drug testing and analysis.

[35]  Cristiana do Vale Pires,et al.  CHECK!NG: A última fronteira para a Redução de Riscos em contextos festivos 1 CHECK!NG: The last frontier for Harm Reduction in party settings , 2015 .

[36]  I. Spruit,et al.  MONITORING SYNTHETIC DRUG MARKETS, TRENDS, AND PUBLIC HEALTH , 2001, Substance use & misuse.

[37]  M. Driscoll,et al.  Vasculopathy related to cocaine adulterated with levamisole: A review of the literature. , 2012, Dermatology online journal.

[38]  Andini Nur Vania Swari.  PERAN UNITED NATIONS OFFICE ON DRUGS AND CRIME (UNODC)DALAM PEMBERANTASAN KOKAIN DI KOLOMBIA 2008-2014 , 2014 .

[39]  M M van Deursen,et al.  Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in The Netherlands. , 2006, Science & justice : journal of the Forensic Science Society.

[40]  Isabelle Giraudon,et al.  Monitoring Ecstasy Content in France: Results From the National Surveillance System 1999–2004 , 2007, Substance use & misuse.

[41]  A. Parrott.  Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity , 2004, Psychopharmacology.

[42]  Link,et al.  UvA-DARE ( Digital Academic Repository ) Monitoring illicit psychostimulants and related health issues , 2011 .

[43]  Marcel de Kort,et al.  Pragmatism versus Ideology: Dutch Drug Policy Continued , 1999 .

[44]  S. Kish,et al.  Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). , 2004, Journal of forensic sciences.

[45]  P. Tossmann,et al.  The Use of Drugs within the Techno Party Scene in European Metropolitan Cities , 2001, European Addiction Research.

[46]  E. Gaertner,et al.  Dermatologic complications from levamisole-contaminated cocaine: a case report and review of the literature. , 2014, Cutis.

[47]  R. Niesink,et al.  The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison. , 2011, Drug testing and analysis.